LabTurbo Biotech (ROCO:7725) EBITDA Margin %: -60.98% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7725 LabTurbo Biotech Corp ROCO:7725
14 GF Score
Price NT$23.00
! 2 Warning Signs
View Full Analysis

What is LabTurbo Biotech EBITDA Margin %?

LabTurbo Biotech ROCO:7725 14 EBITDA Margin % is -60.98% as of Dec. 2025. GuruFocus rates ROCO:7725 with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 939 Biotechnology companies, LabTurbo Biotech ranks worse than 54.63% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. LabTurbo Biotech's EBITDA for the six months ended in Dec. 2025 was NT$-25.74 Mil. LabTurbo Biotech's Revenue for the six months ended in Dec. 2025 was NT$42.21 Mil. Therefore, LabTurbo Biotech's EBITDA margin for the quarter that ended in Dec. 2025 was -60.98%.

LabTurbo Biotech  (ROCO:7725) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

LabTurbo Biotech EBITDA Margin % Related Terms

LabTurbo Biotech EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for LabTurbo Biotech's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LabTurbo Biotech EBITDA Margin % Chart

LabTurbo Biotech Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
61.22 64.45 -4.71 79.62 -116.14

LabTurbo Biotech Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only -72.87 258.24 -150.29 -179.30 -60.98

ROCO:7725 vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, LabTurbo Biotech's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LabTurbo Biotech EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LabTurbo Biotech's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where LabTurbo Biotech's EBITDA Margin % falls into.


ROCO:7725
14GF Score
LabTurbo Biotech Corp ROCO:7725
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LabTurbo Biotech EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

LabTurbo Biotech's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-91.833/79.07
=-116.14 %

LabTurbo Biotech's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-25.735/42.205
=-60.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -60.98% mean?
LabTurbo Biotech (ROCO:7725) has a EBITDA Margin % of -60.98% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on LabTurbo Biotech and its competitors. According to the industry distribution chart, LabTurbo Biotech ranks #513 out of 939 companies in the Biotechnology industry, placing it in the top 54.6%.
Is LabTurbo Biotech's EBITDA Margin % too high?
LabTurbo Biotech's current EBITDA Margin % is -60.98%. Based on the distribution chart, LabTurbo Biotech ranks #513 out of 939 companies in the Biotechnology industry, which is below the industry midpoint. Overall, LabTurbo Biotech has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does LabTurbo Biotech's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, LabTurbo Biotech ranks #513 out of 939 companies for EBITDA Margin %. This places LabTurbo Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on LabTurbo Biotech and its competitors. LabTurbo Biotech's current EBITDA Margin % is -60.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LabTurbo Biotech stock overvalued right now?
LabTurbo Biotech (ROCO:7725) has a current EBITDA Margin % of -60.98%. The current EBITDA Margin % is -60.98%. LabTurbo Biotech's overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For LabTurbo Biotech (ROCO:7725), the current EBITDA Margin % is -60.98% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LabTurbo Biotech Business Description

Address 3F-1, No. 150, Section 4, Chengde Road, Shilin District, Taipei, TWN
LabTurbo Biotech Corp is a company that is mainly engaged in the research and development, production, sales of nucleic acid extraction, genetic testing, genetic testing reagents, instruments, and the operation of sports science venues. Its main products and services include the entire process. Automated precision medical genetic testing systems and reagent kits as well as testing services.
14GF Score

Get the complete analysis for ROCO:7725

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$23.00
Price